NEW YORK (
CHANGE IN RATINGS
Abercrombie & Fitch
(ANF - Get Report)
was downgraded to Market Perform at Wells Fargo. Estimates were also cut, given lower comp sales trends, Wells Fargo said.
was upgraded at Bank of America/Merrill Lynch from Neutral to Buy. $37 price target. Company can deliver above-average growth over the next few years, BofA/Merrill said.
was initiated with a Hold rating at Wunderlich. $68 price target. Company operates in a slow-growth market, where supply has caught up with demand, Wunderlich said.
was downgraded at Keybanc from Buy to Hold. Company lacks near-term catalysts, Keybanc said.
was upgraded at Sterne Agee from Underperform to Neutral. Valuation call, based on a $15 price target, Sterne Agee said.
was downgraded to Sell at TheStreet Ratings.
was upgraded to Buy at TheStreet Ratings.
(GDOT - Get Report)
was downgraded at Goldman Sachs from Buy to Neutral. Company is facing increased competition, which could impede growth, Goldman said. $24 price target.
(HLF - Get Report)
was upgraded at Caris & Company from Average to Buy. $86 price target. Company has strong fundamentals and no longer appears to be on the radar of David Einhorn, Caris said.
Helmerich & Payne
was upgraded at Argus from Hold to Buy, Argus said. $55 price target. Valuation call, as the stock is down about 25% year-to-date, Argus said.
was initiated with a Buy rating at Wunderlich. $20 price target. Company has resumed solid earnings growth, Wunderlich said.
was upgraded at Citigroup to Buy from Neutral following capital plan including deleveraging and new buyback, Citigroup said. $32.50 price target. Company also added to TPL!.
(RVBD - Get Report)
was downgraded from Buy to Neutral at MKM Partners. $16.50 price target. Company is launching new products into a difficult macro environment, MKM said.
was initiated with a Buy rating at Benchmark. $45 price target. Company has good visibility and more than 50% recurring revenue, Benchmark said.
was downgraded at Deutsche Bank to Hold. Company lacks near-term catalysts. $54 price target.
STOCK COMMENTS / EPS CHANGES
Abercrombie & Fitch numbers were cut at UBS. Shares are now seen reaching $60. Estimates were also lowered as European weakness continues, especially at Hollister, UBS said. Buy rating.